Solid Biosciences SLDB
NASDAQ SLDB
$6.85 -0.13 (-1.86%)
At close: Oct 2, 2026 · 4:00 PM EDT

Solid Biosciences (SLDB) Selling, General & Administrative (2017 - 2026)

Updated

Solid Biosciences (SLDB) posted Selling, General & Administrative of $13.12 million for Q2 2026, up 41.4% from $9.28 million a year earlier and up 17.5% from the prior quarter.

Analysis

Solid Biosciences (SLDB) Selling, General & Administrative (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Solid Biosciences was $44.75 million, up 26.4% year-over-year; for FY2025, it was $38.88 million, up 16.8% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 12.5% (FY2020 to FY2025).
  • In prior years, Solid Biosciences' Selling, General & Administrative was $33.3 million in FY2024 (+20.0%), $27.75 million in FY2023 (-4.1%), $28.95 million in FY2022 (+6.7%) and $27.14 million in FY2021 (+25.7%).
  • The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q1 2017.
  • On a year-over-year basis, Selling, General & Administrative has increased in each of the last ten quarters, with growth averaging 23.3% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2026, with growth of 41.4%; the weakest was Q4 2023, with a decline of 10.6%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $11.17 million (Q1 2026), $11.27 million (Q4 2025) and $9.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Solid Biosciences 984.27 Mn 984.27 Mn - 13.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.12 Mn
Mar 31, 2026 11.17 Mn
Dec 31, 2025 11.27 Mn
Sep 30, 2025 9.20 Mn
Jun 30, 2025 9.28 Mn
Mar 31, 2025 9.14 Mn
Dec 31, 2024 9.13 Mn
Sep 30, 2024 7.86 Mn
Jun 30, 2024 8.33 Mn
Mar 31, 2024 7.99 Mn
Dec 31, 2023 6.81 Mn
Sep 30, 2023 6.41 Mn
Jun 30, 2023 7.13 Mn
Mar 31, 2023 7.40 Mn
Dec 31, 2022 7.62 Mn
Sep 30, 2022 7.13 Mn
Jun 30, 2022 6.85 Mn
Mar 31, 2022 7.35 Mn
Dec 31, 2021 7.21 Mn
Sep 30, 2021 7.14 Mn
API Access

Solid Biosciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SLDB&period=max&api_key=YOUR_API_KEY